Alex Bradley
Analyst · ROTH
Thanks, Mark. Before discussing financial guidance, I’d like to reiterate our approach to growth and gross margin expansion. As discussed on our second quarter earnings call, this strategy includes our approach of contracting out our capacity several years in advance of production. The anticipated reduction of our cost per watt produced, the expected benefits from capacity expansion through scaling a largely fixed overhead structure in order to generate incremental contribution margin and our agile contracting approach would both provides the potential realization of incremental revenue and is expected to mitigate freight and certain commodity risks. As we look to 2023 guidance, we continue to see this approach benefiting our forecasted financial results relative to 2022. For the full year, we expect to recognize an average ASP sold of $0.285 per watt, approximately $0.01 higher than in 2022. Looking across the horizon, as is showed in the 10-K filing, as of 31 December 2022, we had a total contracted backlog of 61.4 gigawatts with expected future revenue of $17.7 billion for a portfolio average base ASP of $0.288 per watt, before the application of potential adjusters. As it relates to cost award and our contracting approach and their impacts on both the potential value of the technology adjusters, which are reflected in the 10-K filing and our 2023 financial guidance, I’d like to provide a brief update on the timing of our technology and cost road maps. From a technology road map perspective, we continue to work to prove out both bifaciality and our copper replacement or cure program and are progressing well with both initiatives. However, even if ready for high-volume manufacturing deployment, we expect to elect to push out implementation of these technologies across the majority of the fleet for two reasons. Firstly, technology implementations typically necessitate manufacturing downtime, both to make tooling and process changes and to conduct preproduction trials. And as we’re sold out through 2025 with limited ability to delay shipments, significant downtime would be suboptimal to executing on our delivery commitments. Secondly, we typically roll out technology improvements at our Perrysburg facilities and then, once fully optimized, across the remainder of the fleet. This leads to a potential for greater downtime in Perrysburg during initial rollout, which has the highest opportunity cost given the anticipated value of domestically produced modules, both from an IRA domestic content and Section 45X perspective. Our new dedicated R&D facility, projected to be operational in mid-2024, is expected to alleviate the need for choosing between downtime and implementation by providing a means to optimize these technology improvements with significantly less disruption to our commercial manufacturing lines. With respect to the potential value of the adjusters related to potential future technology improvements, as reflected in the 10-K, the push out of these technology programs will result in a reduction in the supply of products with these technology improvements, leading to an expected reduction in technology adjusters, particularly in 2024 and early 2025. We have correspondingly reduced our estimate for these adjusters from $0.7 billion across 31.4 gigawatts in Q3 to $0.5 billion across 31.5 gigawatts in Q4. From a cost reduction road map perspective, as it relates to cost per watt produced, we ended Q4 2022 5% lower than Q4 of the previous year, at the midpoint of our original forecasted production range of 4% to 6%. This was used to throughput, yield and efficiency improvements and reductions in variable costs, slightly offset by increases in fixed costs. We’ve been able to achieve a sustained cost per watt reduction road map over the last several years, having reduced our cost per watt produced by 18% from Q4 2019 to Q4 2022. On a full year 2022 to 2023 basis, we expect a 1% to 2% reduction in cost per watt produced, driven by improvements in throughput, yield, efficiency and inbound freight, partially offset by higher fixed costs and a headwind from the conversion of all production to high mechanical load modules in 2023 to optimize order fulfillment management and logistics. With regards to high versus standard mechanical load modules, we may reintroduce the stand-alone product in future years. And in doing so, we would expect to see a cost per watt benefit. As it relates to exit rates, comparing Q4 2022 to Q4 2023, we’re forecasting a cost per watt produced increase of 4% to 6% or approximately $0.01 per watt. This is driven by several factors, including costs driven by the expected implementation of bifaciality at our lead line in Perrysburg in Q4 of 2023, which results in a reduction in front side watts, offset by a higher energy production profile; planned downtime associated with our Series 6 throughput optimization in Ohio; and a headwind associated with our Series 7 factory in Perrysburg, exiting its ramp phase in mid to late 2023, but not yet operating at full scale by year-end. As it relates to cost per watt sold, we ended Q4 2022 with a 2% year-over-year increase over Q4 2021, in line with our most recent forecast. This was largely due to higher sales freight and logistics costs. In 2023, we expect sales freight and logistics costs trend back towards pre-pandemic levels throughout the year. Several key metrics, including reliability of schedule, transit times and congestion are currently trending positively. However, transit time volatility generally and labor relations in West Coast ports post potential headwinds. We are working to mitigate these issues through shipping route and port-of-entry optimization and through further utilization of our warehousing network. In addition, as part of our contracting strategy, approximately 67% of our volumes sold in 2023 has some form of sales freight risk coverage. Although given the forecasted reduction in sales freight and logistics costs, we expect limited excess recovery in 2023. On a cents per watt basis, we expect our full year sales freight and logistics costs to be approximately $0.027 per watt, with international transit costs remaining above pre-pandemic norms. Taken together, we forecast cost per watt produced, ramp and underutilization and sales freight and logistics costs to combine to yield a Q4 2022 to Q4 2023 net reduction in cost per watt sold of 9% to 11% and full year 2022 to 2023 cost per watt sold reduction of 7% to 9%. On a full year basis, expected ramp and underutilization costs impact our cost per watt sold reduction by approximately 4 percentage points. With respect to other commodities, we continue to largely mitigate exposure to glass costs through strategic long-term, predominantly fixed price agreements with domestic suppliers that have economic benefits to us as we achieve high levels of production. We do expect the near-term volatility in glass pricing, given that the contractual provisions in our supply contracts relating to input cost adjustments operates on a backward-looking basis. And therefore, we are seeing a slight increase in cost in the first half of 2023, which is expected to then reduce in the second half of the year. From a frame perspective, there’s been a reversion of aluminum and steel rates back to historical levels. We expect these costs to be less of a headwind in 2023. Related to framing costs, we have hedged 90% of our aluminum exposure for our Series 6 U.S. plants in 2023, which is approximately 1/3 of our Series 6 production. In addition, substantially all of our Series 7 production, which utilizes a steel back rail, is subject to contractual steel adjusters. And lastly, with respect to operating expenses, despite a forecasted increase in operating expenses in 2023, particularly related to research and development, we continue to scale manufacturing capacity at a greater rate than operating expenses, leveraging our fixed cost structure to reduce operating expense per watt and increase operating margin. So with this in mind, I’ll next discuss [indiscernible] 2023 financial guidance. Please turn to Slide 9. Strategically, in 2022, we completed the sales of our Japan project development business, our Japan O&M business and our Chilean Luz del Norte asset. In January of this year, we completed the sale of our 10-megawatt Maricao operating asset in India, bringing our PV solar power systems balance on our balance sheet, as of today, to zero. With these sales, we have effectively transitioned back to a module-only company. We do have certain remaining risks, liabilities, indemnities, warranty obligations, accounts payable, accounts receivable, earn-outs, cash collection, dispute resolution and other legacy involvements related to our former systems business. Given the declining impact of our other segment, we will no longer provide segment-specific guidance, but shall in the future note any significant impact from the other segment to our consolidated financials. As it relates to capacity expansion, our factory expansion and upgrades remain on schedule and are expected to impact operating income by approximately $195 million to $220 million in 2023. This is comprised of start-up expenses of $85 million to $90 million primarily incurred in connection with our new factories in Ohio and India; an estimated ramping on the utilization costs of $110 million to $130 million. We anticipate these expansions and upgrades will contribute meaningfully to our production plans in 2024 and beyond. Operationally, in 2023, we’re expecting to produce 11.5 to 12.2 gigawatts of modules, and after taking into account reductions in inventory, fell 11.8 to 12.3 gigawatts. From a capital structure perspective, our strong balance sheet has been and remains a strategic differentiator, enabling us both to weather periods of volatility as well as providing flexibility to pursue growth opportunities including self-funding our Series 6 and Series 7 transitions. We ended 2022 in a strong liquidity position. And coupled with strong forecasted operating cash flows, modular advance payments and our existing India credit facility, we expect to be able to finance our current capital programs without acquiring external financing. We are evaluating putting in place our revolving credit facility to support jurisdictional cash management as well as to provide short-term optionality and expect to address more details on our capital structure and liquidity outlook at our Analyst Day. And finally, a few words on the Inflation Reduction Act. The IRA offers, amongst other incentives, production tax credits for solar modules and solar module components manufactured in the U.S. and sold to third parties. Although we continue to await guidance from the IRS and Treasury regarding these credits under Section 45X of the statute, based on our view of both the intention of the credit and the language of the legislation, we intend to begin recording a corresponding benefit in our financial statements in Q1 of 2023. Following consultation review with outside advisers, our auditors and the SEC, we expect to recognize these credits as a reduction to cost of sales in the period such modules and the integrated eligible components are sold to customers. In addition, these credits will also be shown as government grants receivable on our balance sheet. We encourage you to review the safe harbor statements contained in today’s press release and presentation for the risks related to our receiving the full amount of tax benefits that we believe we are entitled to under the IRA. I’ll now cover the full year 2023 guidance ranges on Slide 10. Our net sales guidance is between $3.4 billion and $3.6 billion; gross margin is expected to be between $1.2 billion and $1.3 billion, which includes $660 million to $710 million of advanced manufacturing production tax credits under Section 45X of the IRA; and $110 million to $130 million of ramp and underutilization costs. SG&A expense is expected to total $175 million to $185 million compared to $165 million in 2022 and $170 million in 2021. R&D expense is expected to total $155 million to $165 million compared to $113 million and $99 million in 2021 and 2022, respectively. The 2023 expense is increasing primarily due to our expectation of adding headcount to our R&D team to further invest in advanced research initiatives. SG&A and R&D expense combined is expected to total $330 million to $350 million. And total operating expenses, which includes $85 million to $90 million of production start-up expense, are expected to be between $415 million and $440 million. Operating income is expected to be between $745 million and $870 million, as inclusive of $195 million to $220 million of combined ramp and underutilization costs and plant startup expenses, and $660 million to $710 million of Section 45X credits. Turning to non-operating items. We expect interest income, interest expense and other income to net to $60 million to $75 million, which is predominantly driven by higher expected interest rates for deposits. Full year tax expense is forecast to be $60 million to $85 million. Tax expense to 2023 is largely driven by the U.S. blended tax rate of approximately 25%. However, we also expect a significant loss in the year as we begin manufacturing for which we will not receive a current benefit, leading to a higher effective tax rate. This results in a full year 2023 earnings per diluted share guidance range of $7 to $8. Note from an earnings cadence perspective, we anticipate our earnings profile will be higher in the second half of the year, both due to contractual delivery schedules as well as the timing of first sales of our Series 7 products, which are forecast to begin shipping in Q3 of this year. This is forecasted to result in an increase in inventory at our distribution centers in the first half of 2023, which is expected to reverse in the second half of the year. Additionally, Section 45X credits, recognized, will increase after Q1, driven by both the timing of volumes sold as well as the inventory lag, whereby products sold in the early part of 2023 may have been manufactured in 2022. Capital expenditures in 2023 are expected to range from $1.9 billion to $2.1 billion as we complete the construction of our Ohio and India Series 7 plants, commence construction on our Alabama Series 7 plant, implement throughput upgrades to the fleet and invest in other R&D-related programs. Our year-end 2023 net cash balance is anticipated to be between $1.2 billion and $1.5 billion. The decrease from our 2022 year-end net cash balance is primarily due to capital expenditures, which we expect will be partially offset by financing proceeds and customer advance payments. Turning to Slide 11, I’ll summarize the key messages from today’s call. Demand has been robust, with 12 gigawatts of net bookings since the prior earnings call, leading to a record contracted backlog of 67.7 gigawatts. Our opportunity pipeline remains strong with a global opportunity set to 93.1 gigawatts, including mid- to late-stage opportunities of 58 gigawatts. On the supply side, we continue to expand our manufacturing capacity and expect to exit 2026 with approximately 21.4 gigawatts of nameplate capacity, including approximately 10.7 gigawatts of nameplate capacity in the U.S. We are, as previously announced, adding a new dedicated R&D facility in Ohio, projected to be operational in mid-2024, which we believe will allow us to optimize technology improvements with significantly less disruption to our commercial manufacturing lens. We ended the year with a gross cash balance of $2.6 billion or $2.4 billion net of debt, which is an increase to both gross and net cash of $800 million versus the prior year. We believe this puts us in a position of strength to expand our capacity, invest in research, development and technology improvements and pursue other strategic opportunities. And finally, we’re forecasting full year 2023 earnings per diluted share of $7 to $8. And with that, we conclude our prepared remarks and open the call for questions. Operator?